Hemodynamic Shock Flashcards

(65 cards)

1
Q

Shock definition

A

potentially fatal physiologic reaction, state of acute circulatory failure, hypotension
Resulting from various conditions:
* Infection
* Injury
* Hemorrhage
* Dehydration
* Heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hypotension definition

A

SBP < 90 mmhg
or
↓ 40 mmHg from baseline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Shock characterization

A

↓organ perfusion + inadequate O2 delivery = end organ dysfunction
Characterized by cellular dystonia
1. Diminished blood circulation
2. Inadequate o2 delivery (DO2) to tissues for given oxygen consumption (VO2)
3. Results in anaerobic metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Outcomes of shock

A
  1. Multi-organ system failure (MOSF)
  2. Death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CNS dysfunction

A

encephalopathy
cortical necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cardiac dysfunction

A

tachycardia, bradycardia
ventricular ectopy
MI, depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pulmonary dysfunction

A

acute respiratory failure
ARDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Renal dysfunction

A

Pre-renal insults
AKI
Acute tubular necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

GI dysfunction

A

erosive gastritis
Ileus
pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hepatic dysfunction

A

ischemic hepatitis
cholestasis
shock liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Metabolic dysfunction

A

hyperglycemia, glycogenolysis, gluconeogenesis, hypoglycemia (late)

hypertriglyceridemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Immune system dysfunction

A

gut barrier fx
cellular/humoral immunity depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Vital signs: CV organ compromise

A

Cardiac index <2.2 L/min/m2 (invasive)
SBP<90
or MAP < 65

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Vital signs: tissue hypoperfusion

A

cold clammy mottled
Lactate
SCVO2<65 or SCO2<60

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Vital signs: organ dysfunction

A

Encephalopathy, lethargy, confusion
UOP <0.5 ml/kg/hr
Liver dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hemodynamic parameters

A

BP = CO x SVR
CO = HR x SV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

SV

A

preload
intrinsic contractility
afterload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

SVR

A

increases with vasoconstriction (cold skin)
decreases with vasodilation (warm skin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

MAP calculation

A

⅓ SBP + ⅔ DBP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

MAP

A

cardiac output
vascular resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

CO

A

heart rate x stroke volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Monitoring Devices

A

CVC - subclavian
PAC - Swan ganz
Arterial line - radial artery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Central venous catheter (CVC)

A

Measures: Venous blood gas (SCVO2 >65%)
Administers: Fluids, Vasopressors, Antimicrobials, TPN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Pulmonary Artery Catheter (PAC)

A

Measures :
* Pulmonary capillary wedge pressure
- Preload (LV end diastolic volume)
- Critical to assess volume status
* Cardiac output/cardiac index
* Mixed venous oxygen saturation (SVO2)
* Systemic vascular resistance (SVR)
- May get if vasodilated - generally not done or recorded

Not commonly used - several complications
Infections, ruptured pulmonary artery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Arterial Line
radial artery, continuous feedback Measures MAP, SBP and DBP, ABG
26
Types of Shock
Hypovolemic - trauma Cardiogenic - acute MI Distributive - septic Obstructive - PE, pulm HTN
27
Hemodynamic optimization
Assess volume status (preload) Restore MAP ≥ 65 mmHg Normalize lactate < 2 mmol/L Venous oxygen saturation (VBG) PA catheter: SVO2 > 60% CVC: SCVO2 >65% HR < 100 BPM PCWP = 12-15 mmhg (swan gans/PAC) Cardiac index >2.2 L/min/m2 Maintain oxygen delivery * Hbg 7-9 gm/dL * Arterial saturation > 88-92% * SVO2/SCVO2 > 65%/70% Reversal of oxygen dysfunction * Lactate clearance to <2 mmol/L or normalization Maintain urine output * >0.5 ml/kg/hr Reverse encephalopathy
28
Optimizing preload
Fluid responsive = increased cardiac output Blood pressure alone is not a reliable indicator of cardiac output Stroke volume = amount of blood able to push out of heart Preload = based on how much volume we have Trend: drastically increase preload with increased SV As you keep giving more volume, SV may not change as much→ overshooting can put someone in heart failure/acute MI (depress stroke volume by overextending LV) – would req diuresis
29
Hypovolemic Shock
#1 cause of death in those <45 y/o (trauma/hemorrhagic shock) Inappropriately low and sudden loss of intravascular volume
30
Hypovolemic - circulatory
Due to decreased preload (stroke volume) → HR increase Increased afterload – Try to clamp down and shunt blood to brain/heart (SNS vasoconstriction to maintain BP) Compensatory increase in SVR (BP/CO) Venous = arterial
31
Hemodynamic Shock Tx
Identify source of loss - surgical hemostasis may be required Hemorrhage - replace blood * Hgb: PRBCs * May also need to give FFP and platelets * Anticoagulation reversal (if AC cause of bleeding) GI losses, burns, third spacing * Fluid replenishment - titrate to target * Crystalloids (check HR, SBP, MAP) * Albumin - occasionally
32
Cardiogenic Shock
Failure of left ventricle to deliver blood due to impaired stroke volume or heart rate “pump failure”
33
Causes of cardiogenic shock
associated with CV disease ACUTE MYOCARDIAL INFARCTION Arrhythmias Heart block, afib, vtach End stage heart failure (ADHF) Valve failure/disease Dilated cardiomyopathy etc
34
Cardiogenic - circulatory
Failure to empty left ventricle High venous pressure = fluid extravasation + edema Tissue perfusion: pooling in extremities; venous O2 sat low Preload: increases - unable to circulate volume Cardiac output: decreased d/t mechanism of injury Afterload: increases - senses lack of perfusion Compensatory mechanism - vasoconstriction to maintain BP Venous fluid >> arterial
35
Cardiogenic Shock tx
MI = Revascularization - cardiac catheterization or CABG Arrhythmia = Try to achieve sinus rhythm (BB, CCB, antiarrhythmics) Advance methods * Left ventricular assist devices (LVAD) * Impella * HeartMate and Tandem Heart ECMO
36
Distributive Shock
Characterized by pronounced vasodilation – may have component of intravascular volume depletion// Not as much volume returning (lacks preload)
37
Distributive Shock Causes
* Septic shock - classic example * Anaphylaxis * Neurogenic, myxedema coma (thyroid insufficiency) * Adrenal insufficiency, hepatic insufficiency * Pancreatitis
38
Distributive - circulatory
Vasodilation, hypovolemia = reduced SVR (preload) Venous: Volume returning to the heart is reduced = Therefore, decreased preload Arteries: capillary leak worses hypovolemia = edema Compensation Increase heart rate to maintain cardiac output (comp the low SV) CO = HR x SV
39
Septic Shock
Infection - release of proteins/inflammatory mediators → vasodilation Early on - able to compensate (initial elevation CO and perfusion) Later on - depressed CO and perfusion long term
40
Obstructive shock
nonpharm mechanism Results from critical decrease in left ventricular stroke volume or increase in left ventricle outflow obstruction – noncardiogenic However, preload measurement will appear “elevated” due to ‘obstruction’ (increased intrathoracic pressure/LV) Compensation: Increased afterload
41
Obstructive - circulatory
backpressure = venous congestion sympathetic overactivity = arterial vasoconstriction to maintain BP Venous fluid > arterial
42
Common causes of distributive shock
Pulmonary embolism = Treat with thrombolytic or remove mechanically Severe pulmonary hypertension (RV artery – decreased flow) Tension pneumothorax= Needle decompression Pericardial tamponade Manifestation of thrombolytic therapy, acute MI (pericardium fills with fluid, unable to pump)= Drain fluid
43
Fluid therapy - shock states
Frank-starling curve theory = increases stroke volume, cardiac output, delivery O2 Use fluid asap to prevent need for vasopressors! * Crystalloid 30 ml/kg over 15-30 min (LR/NS) via central line - Then by 10 ml/kg boluses * Cardiogenic shock - 100-200 ml bolus Optimize preload
44
starting vasoactive agents (vasopressors)
Start when MAP < 65 mmhg despite fluid admin CVC req. for administration + arterial line for monitoring
45
Vasopressors/Inotropes
NE, EPI, DA (chronotropy), PE, ADH Dobutamine
46
Norepinephrine (NE) MOA/effect
Alpha agonist Increases MAP via peripheral vasoconstriction + b1 minimal fx on HR at lower doses
47
Norepinephrine (NE) use
septic shock #1 0.01 - 3 mcg/kg/min or 5-65 mcg/min Downregulation of a receptor - higher dose req. Improves RBF in fluid resuscitated patients
48
Norepinephrine (NE) ADR
Major ADR: Significant vasoconstriction
49
Epinephrine (EPI) MOA/effect
Dose dependent activity Low: b1 (↑ HR/SV), b2 vasodilation High: a1 stimulation Distribution of receptors in periphery determines pharmacologic effects
50
Epinephrine (EPI) use
0.05 - 2 mcg/kg/min Increases MAP in septic shock secondary to ↑ HR/SV 2nd line for Sepsis B2 skeletal muscle receptor stimulation = may increase aerobic lactate production (maybe don’t use lactate CL to guide resuscitation) Useful for Anaphylactic shock
51
Epinephrine (EPI) ADR
ADR: limits utility at higher doses - tachycardia, arrhythmias, cardiac ischemia, peripheral vasoconstriction, reduced RBF, hyperglycemia, hypokalemia
52
Dopamine (DA) MOA/effect
EPI/NE precursor Dose dependent pharmacology mcg/kg/min < 5 = dopaminergic * Vasodilation renal/mesenteric/coronary * ↑RBF, GFR, Na excretion 5-10 = b1 adrenergic * ↑ cardiac contractility, HR * ↑ NE release >10 = a1 adrenergic * Arterial vasoconstriction Maximum effects: 20 mcg/kg/min
53
Dopamine (DA) use
Most effective: hypotensive w/ depressed cardiac function or cardiac reserve Use if: * Low risk for arrhythmia * Significant bradycardia Critically ill: may not respond in traditional dose-dependent fashion
54
Dopamine (DA) ADR
Major ADR Tachycardia Arrhythmogenesis High dose: peripheral vasoconstriction
55
Phenylephrine (PE) MOA/effect
selective a1 agonist High dose - may stimulate beta receptors Peripheral vasoconstriction – purported reflex bradycardia
56
Phenylephrine (PE) use
Usual: 0.5 - 9 mcg/kg/min Lower dose for non-septic shock Not for septic shock unless NE causes significant tachyarrhythmia, CO is high and BP persistently low, or other therapies are ineffective
57
Phenylephrine (PE) ADR
severe vasoconstriction bradycardia myocardial ischemia
58
Dobutamine (DB) MOA/effect
B1 inotrope Inotropic action + vasodilation (BP effects depend on volume status)
59
Dobutamine (DB) use
2 - 20 mcg/kg/min Added to treatment of shock when cardiac output or ScO2/ScvO2 goals have not been achieved with vasopressor therapy Often used for cardiogenic shock (pump failure)
60
Vasopressin (ADH) MOA/effect
Released from pituitary - in response to ↓blood volume or ↑plasma osmolarity V1: directly constricts smooth muscle + indirectly increases catecholamine release V2: ADH activity V3: increases ACTH release
61
Vasopressin (ADH) use
Relative deficiency of ADH in septic shock Low dose 0.01 - 0.04 units/min to increase MAP in catecholamine-resistant hypotension Sepsis dose: 0.03 units/min not to be used as monotherapy in sepsis Goal: reduce concurrent vasopressor doses
62
Vasopressin (ADH) ADR
ADR: cardiac + mesenteric ischemia (w/ higher doses)
63
Giapreza (AGII) MOA/effect
Angiotensin II - peptide hormone of RAAS vasoconstriction + aldosterone release
64
Giapreza (AGII) use
Indicated for septic shock + distributive shock Given by central line continuous infusion d/t short half life <1 min * Titrated for MAP goal * Add to standard therapy (NE) * Used to reduce catecholamine vasopressor use RISK: thromboembolism
65